REMSCLE registrynintedanibSystemic Sclerosis (SSc)Interstitial lung disease (ILD)SSc-ILD
…ness and safety of nintedanib in patients with SSc-ILD from the REMSCLE registry after one year of treatmentMaterial and Methods Patients with S…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: REMSCLE registry ×
REMSCLE registry
This institution is selected. Its supporting articles are shown below.